However, the HLA-restricted target-recognition remained a hurdle due to MHC-specificity, on-target/off-tumor toxicity and tumor escape mechanisms, such as MHC-downregulation [92,93,94,95]. This evidence concerns the gene HLA-C and neoplasm.